T Onoshi

1.5k total citations · 1 hit paper
8 papers, 1.1k citations indexed

About

T Onoshi is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, T Onoshi has authored 8 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Pulmonary and Respiratory Medicine and 3 papers in Molecular Biology. Recurrent topics in T Onoshi's work include Lung Cancer Research Studies (3 papers), Lung Cancer Treatments and Mutations (3 papers) and Cancer therapeutics and mechanisms (2 papers). T Onoshi is often cited by papers focused on Lung Cancer Research Studies (3 papers), Lung Cancer Treatments and Mutations (3 papers) and Cancer therapeutics and mechanisms (2 papers). T Onoshi collaborates with scholars based in Japan, Australia and France. T Onoshi's co-authors include David H. Johnson, B Lebeau, R. Arriagada, Daniel C. Ihde, Martin H.N. Tattersall, Merrill S. Kies, Robert L. Souhami, Ola Brodin, Michael C. Perry and Kell Østerlind and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Cancer.

In The Last Decade

T Onoshi

7 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Meta-Analysis of Thoracic Radiotherapy for Small-Cell Lung Cancer

1992 932 citations Jean‐Pierre Pignon, R. Arriagada et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
T Onoshi Japan	5	958	684	573	243	38	8	1.1k
P Chomy France	10	1.3k 1.4×	547 0.8×	1.0k 1.8×	351 1.4×	32 0.8×	28	1.5k
Margaret Edison United States	8	563 0.6×	437 0.6×	284 0.5×	225 0.9×	29 0.8×	10	669
Colin Trask United Kingdom	11	543 0.6×	228 0.3×	488 0.9×	159 0.7×	40 1.1×	12	837
Mary Ellen Patno United States	11	440 0.5×	261 0.4×	361 0.6×	113 0.5×	71 1.9×	13	733
Anne Aupérin France	6	1.1k 1.2×	722 1.1×	855 1.5×	185 0.8×	29 0.8×	9	1.3k
Sherif Y. El Sharouni Netherlands	10	498 0.5×	305 0.4×	456 0.8×	111 0.5×	69 1.8×	26	728
N.H. Gower United Kingdom	13	871 0.9×	217 0.3×	930 1.6×	216 0.9×	60 1.6×	17	1.3k
Astrid Keijser Netherlands	6	479 0.5×	342 0.5×	273 0.5×	102 0.4×	22 0.6×	11	570
Osamu Ishimoto Japan	11	795 0.8×	439 0.6×	480 0.8×	354 1.5×	16 0.4×	34	995
C. Grafton Canada	9	349 0.4×	217 0.3×	242 0.4×	141 0.6×	27 0.7×	18	531

Countries citing papers authored by T Onoshi

Since Specialization

Citations

This map shows the geographic impact of T Onoshi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T Onoshi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T Onoshi more than expected).

Fields of papers citing papers by T Onoshi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T Onoshi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T Onoshi. The network helps show where T Onoshi may publish in the future.

Co-authorship network of co-authors of T Onoshi

This figure shows the co-authorship network connecting the top 25 collaborators of T Onoshi. A scholar is included among the top collaborators of T Onoshi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T Onoshi. T Onoshi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Kunitoh, Hideo, Kyohei Watanabe, T Onoshi, et al.. (1996). Phase II trial of docetaxel in previously untreated advanced non-small-cell lung cancer: a Japanese cooperative study.. Journal of Clinical Oncology. 14(5). 1649–1655. 119 indexed citations

2.

Onoshi, T, K. Watanabe, Kiyoyuki Furuse, et al.. (1995). Late phase II trial of RP 56976 (docetaxel) in patients with non-small-cell lung cancer. Lung Cancer. 13(1). 99–99. 7 indexed citations

3.

Pignon, Jean‐Pierre, R. Arriagada, Daniel C. Ihde, et al.. (1992). A Meta-Analysis of Thoracic Radiotherapy for Small-Cell Lung Cancer. New England Journal of Medicine. 327(23). 1618–1624. 932 indexed citations breakdown →

4.

Kimura, I, et al.. (1975). Combination Chemotherapy of Bronchogenic Carcinoma with FOBEM (5 Fluorouracil, Vincristine, Bleomycin, Cyclophosphamide and Mitomycin C) Therapy. Haigan. 15(4). 289–294. 1 indexed citations

5.

Kimura, I, et al.. (1974). Combination chemotherapy with anticancer agents and OK-432.. PubMed. 28(6). 411–21.

6.

Kimura, I, et al.. (1974). Studies on the host-mediated action of the streptococcal preparation, OK-432, in cancer chemotherapy.. PubMed. 28(6). 423–31. 7 indexed citations

7.

Kimura, Ikuro, et al.. (1972). Treatment of malignant lymphomas with bleomycin. Cancer. 29(1). 58–60. 29 indexed citations

8.

Kimura, Ikuro, et al.. (1970). Treatment of Lung Cancer with Bleomycin. Okayama Igakkai Zasshi (Journal of Okayama Medical Association). 82(11-12). 575–584. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact